Semaglutide 30 mg – Appetite‑Control & Metabolic‑Support Peptide
What is Semaglutide? Semaglutide is a synthetic GLP‑1 analogue. In low‑dose, once‑weekly protocols it gently signals satiety and improves metabolic efficiency without causing hypoglycaemia.
Key Benefits (user‑reported)
- Appetite‑Control – promotes a feeling of fullness, helping reduce cravings.
- Metabolic‑Support – assists the body in maintaining a balanced energy‑utilisation pattern.
- Steady Energy – helps avoid mid‑day energy crashes.
- Weight‑Management Aid – can support modest, sustainable weight‑maintenance when combined with diet & exercise.
- Research‑Grade Purity – ≥ 99 % HPLC‑verified, ideal for personal‑wellness studies.
Product Specifications
| Specification |
Detail |
| Dosage per vial |
30 mg lyophilized Semaglutide (synthetic GLP‑1 analogue) |
| Purity |
≥ 99 % (HPLC) |
| Form |
Lyophilized powder in amber glass vial (30 mg) |
| Storage |
–20 °C, desiccated; protect from light & moisture |
| Shelf‑life |
24 months (when stored correctly) |
| SKU |
PL‑SEM‑030 |
| GTIN / UPC |
00734581923945 |
How to Use (well‑being protocol)
- Reconstitute with 3 mL sterile bacteriostatic water → 10 mg/mL solution.
- Typical dose: 0.025 mL (0.25 mg) sub‑cutaneously **once per week**, preferably in the evening.
- If a stronger effect is desired, increase to 0.05 mL (0.5 mg) per injection – **do not exceed 1 mg per week**.
- No cycling required; a 2‑week break after 6 months of continuous use is advisable for long‑term wellness.
Disclaimer
This peptide is supplied for **personal, non‑clinical research use only**. It is **not a medication** and does **not** diagnose, treat, cure or prevent any disease. Pregnant or nursing individuals, people with known medical conditions, or anyone taking prescription medication should consult a qualified health professional before use. Keep out of reach of children.